Business
Cardax Announces Launch of ZanthoSyn™ in Hawaii GNC Stores
Cardax Announces Launch of ZanthoSyn™ in Hawaii GNC Stores.
About this update from Cardax Inc
[{"type":"text","content":"\n \n Cardax, Inc. (“Cardax”) (OTCQB:CDXI) announced today that ZanthoSyn, \n Cardax’s safe anti-inflammatory supplement for general health,* is being \n rolled out to all 29 GNC stores in Hawaii, where Cardax is \n headquartered. GNC Holdings, Inc. (“GNC”) (NYSE:GNC), is a leading \n global specialty health, wellness, and performance retailer.\n \n \n The marketing and distribution program leverages Cardax’s successful \n ZanthoSyn physician education program and GNC’s knowledgeable sales and \n marketing staff—with the goal of building ZanthoSyn brand awareness and \n positive consumer experience. Once the program is established in Hawaii, \n Cardax plans to expand to the US mainland.\n \n \n “We see the convergence of the health and wellness arena with sound \n science as the future of healthcare,” said Cardax CEO, David G. \n Watumull. “GNC’s commitment to science based, physician friendly \n consumer health products, its broad retail reach, and its knowledgeable \n sales staff make GNC an ideal retail partner for us,” he added.\n \n \n Said George Bickerstaff, Cardax Chairman of the Board, “Today’s \n announcement concerning GNC demonstrates our continuing progress in the \n execution our strategy to develop products and build partnerships that \n serve our customers and communities.”\n \n \n Since launching ZanthoSyn in August 2016, Cardax has met with more than \n eighty physicians and other healthcare professionals in Hawaii. \n Combined, these physicians treat more than 100,000 patients, many of \n whom have inflammatory health issues. Feedback has been encouraging, \n with physician acceptance converting into purchases through the \n ZanthoSyn website. The GNC retail channel will offer patients another \n fulfillment choice.\n \n \n The negative impact of chronic inflammation on optimal health has been \n well established scientifically. ZanthoSyn contains astaxanthin, a \n clinically studied ingredient with safe anti-inflammatory activity \n supportive of general health.*\n \n \n About Cardax\n \n \n Cardax devotes substantially all of its efforts to developing and \n commercializing safe anti-inflammatory dietary supplements and drugs. \n Cardax is initially focusing on astaxanthin, which is a powerful and \n safe naturall...